試す 金 - 無料
Clinical trials for generics proposed
Financial Express Chennai
|October 11, 2025
EVEN AS INDIAN drug-makers have heaved a sigh of relief with the United States' decision to shelve the plan to extend the tariff hikes to generic medicines, a key change is in the offing in domestic regulations that will spell trouble for them.
The country's drug regulator - Central Drugs Standard Control Organisation (CDSCO) - has proposed to close the easy route for pharma
このストーリーは、Financial Express Chennai の October 11, 2025 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Financial Express Chennai からのその他のストーリー
Financial Express Chennai
Will capping credit card interest rates help?
The federal cap that Trump has proposed would, in theory, prevent issuers from gouging customers. But not everyone agrees it would be good for Americans
3 mins
February 24, 2026
Financial Express Chennai
Gurugram beats Mumbai in ultra luxury home sales
Millennium City records 24,120-cr high-end deals
2 mins
February 24, 2026
Financial Express Chennai
Centre reopens PLI scheme for key bulk drugs
THE GOVERNMENT HAS reopened applications under the performance-linked incentive (PLI) scheme for the production of two critical bulk drugs: the broad-spectrum antibiotic meropenem and the antiretroviral medicine ritonavir.
1 min
February 24, 2026
Financial Express Chennai
AU SFB denies wrongdoing, shares tank 5%
SHARES OF AU Small Finance Bank fell 7.6% intraday before closing 5.3% lower at ₹974.45 on the BSE on Monday, after the lender clarified that there was no indication of fraud or financial impact following its de-empanelment by the Haryana government on February 18.
1 min
February 24, 2026
Financial Express Chennai
White House tariff defeat has given Europe ammo
AT FIRST GLANCE, very little has changed for the European Union’s terms of trade with the US following President Donald Trump’s tariff defeat at the Supreme Court on Friday.
2 mins
February 24, 2026
Financial Express Chennai
Bitcoin slides below $65K amid tariff woes
BITCOIN BRIEFLY SLID below $65,000 on Monday for the second time this month, roiled by uncertainty over the status of US tariffs.
1 min
February 24, 2026
Financial Express Chennai
WhatsApp tells SC it will comply with NCLAT order
GLOBAL TECH GIANTS Meta Platforms and WhatsApp told the Supreme Court on Monday that they will comply with the NCLAT’s directions for extending the Competition Commission of India’s (CCI) privacy and consent guidelines to advertising-related data.
1 min
February 24, 2026
Financial Express Chennai
Trump warns nations of steep tariffs
US PRESIDENT CAUTIONS COUNTRIES ON REVISITING TRADE AGREEMENTS
1 mins
February 24, 2026
Financial Express Chennai
Novo Nordisk's obesity shot trails Lilly rival
NOVO NORDISK'S NEXT-GENERATION obesity drug CagriSema underperformed Eli Lilly’s Zepbound in a head-to-head trial, the Danish drug-maker said on Monday, as it suffered a setback in its fight to regain leadership of the weight loss market.
1 min
February 24, 2026
Financial Express Chennai
Focus on margins, global demand, says LTTS CEO
L&TTECHNOLOGY SERVICES (LTTS) plans to exit commoditised and non-core segments while doubling down on high-value engineering and artificial intelligence (AI) to strengthen profitability.
1 mins
February 24, 2026
Listen
Translate
Change font size

